Abbreviations

Abbreviations

GMB

Adult glioblastoma

pHGG

Paediatric high-grade glioma

UNCAN

EU initiative for understanding cancer

MRI

Magnetic resonance imaging 

SOC

Standard of care

I/O

Immuno-oncology

TTF

Tumour treating fields

Spatial proteomics named 2024 Method of the Year by Nature Methods

Spatial proteomics has been named 2024 Method of the Year by Nature Methods. This technique, which maps protein distributions within tissues with high resolution, is central to the GLIOMATCH project, where we use it to study the glioblastoma tumour microenvironment.

Key contributions to this work come from Frederik De Smet’s lab at KU Leuven, through the KU Leuven Institute for Single Cell Omics (LISCO), which holds expertise in multiplex immunohistochemistry (mIHC), advanced bioinformatics, and cutting-edge spatial mapping technologies like MILAN, Phenocycler, and COMET by Lunaphore. Meanwhile, Aspect Analytics supports the integration of multi-omics data from various spatial proteomics platforms, enabling a comprehensive understanding of tissue biology and protein interactions.

To find out more about how GLIOMATCH uses spatial proteomics, visit our project and work plan pages.

Follow GLIOMATCH on LinkedIn and Facebook for more information on brain tumour research and updates on our milestones towards improving the clinical outcomes of GBM and pHGG.

More Posts

GLIOMATCH: Explained with Dr. Kathrin Cresswell

In this episode of the GLIOMATCH: Explained video series, Dr. Kathrin Cresswell, Professor of Digital Innovations in Health and Care at the University of Edinburgh, explains how GLIOMATCH is working to ensure the successful use and implementation of its novel data platform. We’ve summarised the interview in this news piece.

GLIOMATCH shares its work at the EU Cancer Mission Showcase in Brussels

On World Brain Tumour Day 2026, GLIOMATCH participated in the European event “Advancing Brain Cancer Research: From policy action to scientific breakthroughs” at the European Parliament in Strasbourg. The event highlighted the urgent need to accelerate brain cancer research, strengthen European collaboration and turn scientific progress into improved care for patients.

Highlights from partner talks at EANO 2026

The KU Leuven team attended EANO 2026 in Rome and Chiara Caprioli and Frederik De Smet presented glioblastoma research and a patient-derived brain tumour model. Discover highlights from the conference.